Therapeutic targets in the podocyte: Findings in anti-slit diaphragm antibody-induced nephropathy

Journal of Nephrology

Volumn 22, Issue 4, 2009, Pages 450-456

  Kawachi, Hiroshi ^a   Han, Gi Dong ^a,b   Miyauchi, Naoko ^a   Hashimoto, Taeko ^a   Suzuki, Koichi ^a   Shimizu, Fujio ^a,c  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Yeungnam University   (South Korea)

^c NIIGATA SEIRYO UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Ephrin B1; IP 10; Nephrin; Slit diaphragm; SV2B

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CELL PROTEIN; EPHRIN B1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCLONAL ANTIBODY; NEPHRIN; RAB PROTEIN; SLIT DIAPHRAGM ANTIBODY; SYNAPTIC VESICLE PROTEIN 2B; SYNAPTOBREVIN 2; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NERVE PROTEIN; SV2B PROTEIN, HUMAN;

ANTIGEN ANTIBODY REACTION; ARTICLE; DOWN REGULATION; KIDNEY DISEASE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEINURIA; ANIMAL; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CHEMOKINE CXCL10; EPHRIN-B1; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PODOCYTES; PROTEINURIA; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 70249101386     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Arakawa M. A scanning electron microscopy of the glomerulus of normal and nephrotic rats. Lab Invest. 1970;23:489-497.
2. Yamada E. The fine structure of the renal glomerulus of the mouse. J Biophys Biochem Cytol. 1955;1:551-556.
3. Farquhar MG, Wissig SL, Palade GE. Glomerular permeability: Part I: ferritin transfer across the normal glomerular capillary wall. J Exp Med. 1961;113:47-66.
4. Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol. 1974;60:423-433.
5. Orikasa M, Matsui K, Oite T, Shimizu F. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol. 1988;141:807-814.
6. Kestila M, Lenkkeri U, Mannikko M, et al. Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:572-578.
7. Ruotsalainen V, Ljungberg P, Wartinovaara J, et al. Nephrin is specifically located at the site of the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A. 1999;96:7962-7967.
8. Kawachi H, Koike H, Kurihara H, et al. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int. 2000;57:1949-1961.
9. Topham PS, Kawachi H, Haydar SA, et al. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest. 1999;104:1559-1566.
10. Kawachi H, Koike H, Shimizu F. Molecular structure and function of the slit diaphragm: expression of nephrin in proteinuric states and in developing glomeruli. Nephrol Dial Transplant. 2002;17:20-22.
11. Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000;24:349-354.
12. Ahola H, Wang S-X, Luimula P, Solin M-L, Holzman LB, Holthofer H. Cloning and expression of the rat nephrin homologue. Am J Pathol. 1999;155:907-913.
13. Furness PN, Hall LL, Shaw JA, Pringle JH. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant. 1999;14:1234-1237.
14. Kawachi H, Koike H, Kurihara H, Sakai T, Shimizu F. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol. 2003;14:46-56.
15. Doublier S, Ruotsalainen V, Salvidio G, et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol. 2001;158:1723-1731.
16. Horinouchi I, Nakazato H, Kawano T, et al. In situ evaluation of podocin in normal and glomerular diseases. Kidney Int. 2003;64:2092-2099.
17. Shih NY, Li J, Karpitski V, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science. 1999;286:312-315.
18. Donoviel DB, Freed DD, Vogel H, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol. 2001;21:4829-4836.
19. Sellin L Huber TB, Gerke P, Quack I, Pavenstädt H, Walz G. NEPH1 defines a novel family of podocin interacting proteins. FASEB J. 2003;17:115-117.
20. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308:1801-1804.
21. Reiser J, Polu KR, Moller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005;37:739-744.
22. Han GD, Koike H, Nakatsue T, et al. IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis. J Am Soc Nephrol. 2003;14:3111-3126.
23. Han GD, Suzuki K, Koike H, et al. IFN-inducible protein-10 plays a pivotal role in maintaining the slit-diaphragm function by regulating the cell-cycle balance of the podocyte. J Am Soc Nephrol. 2006;17:442-453.
24. Miyauchi N, Saito A, Karasawa T, et al. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli. J Am Soc Nephrol. 2006;17:2748-2759.
25. Hashimoto T, Karasawa T, Saito A, et al. Ephrin-B1 localizes at the slit diaphragm of the glomerular podocyte and associates with nephrin. Kidney Int. 2007;72:954-964.
26. Suzuki K, Han GD, Miyauchi N, et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol. 2007;170:1841-1853.
27. Kawachi H, Kurihara H, Topham PS, et al. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol. 1997;273:F984-F993.
28. Kawachi H, Matsui K, Orikasa M, Morioka T, Oite T, Shimizu F. Quantitative studies of monoclonal antibody 5-1-6-induced proteinuric state in rats. Clin Exp Immunol. 1992;87:215-219.
29. Takashima N, Kawachi H, Oite T, Nishi S, Arakawa M, Shimizu F. Effect of chlorpromazine on kinetics of injected monoclonal antibody in MoAb-induced glomerular injury. Clin Exp Immunol. 1993;91:135-140.
30. Narisawa M, Kawachi H, Oite T, Shimizu F. Divalency of the monoclonal antibody 5-1-6 is required for induction of proteinuria in rats. Clin Exp Immunol. 1993;92:522-526.
31. Blanz RC, Gabbal FB, Peterson O, et al. Water and protein permeability is regulated by the glomerular epithelial slit diaphragm. J Am Soc Nephrol. 1994;4:1957-1964.
32. Fujigaki Y, Morioka T, Matsui K, et al. Structural continuity of filtration slit (slit diaphragm) to plasma membrane of podocyte. Kidney Int. 1996;50:54-62.
33. Schnabel E, Anderson M, Farquhar MG. The tight junction protein ZO-1 is concentrated along slit diaphragm of the glomerular epithelium. J Cell Biol. 1990;111:255-263.
34. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084-1097.
35. Gasperini S, Marchi M, Calzetti F, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol. 1999;162:4928-4937.
36. Sauty A, Dziejman M, Taha RA, et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol. 1999;162:3549-3558.
37. Uguccioni M, Gionchetti P, Robbiani DF, et al. Increased expression of IP-10, IL-8. MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol. 1999;155:331-336.
38. Dwinell MB, Lugering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology. 2001;120:49-59.
39. Ren X, Kennedy A, Colletti LM. CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocytes in culture. Shock. 2002;17:513-520.
40. Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 1997;8:207-219.
41. Sasaki S, Yoneyama H, Suzuki K, et al. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol. 2002;32:3197-3205.
42. 2+ regulators in neurotransmitter release. Neuron. 1999;24:1003-1016.
43. Heese K, Nagai Y, Sawada T. Identification of a new synaptic vesicle protein 2B mRNA transcript which is up-regulated in neurons by amyloid peptide fragment (1-42). Biochem Biophys Res Commun. 2001;289:924-928.
44. Schivell AE, Batchelor RH, Bajjalieh SM. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin. J Biol Chem. 1997;271:27770-27775.
45. Lazzell DR, Belizaire R, Thakur P, Sherry DM, Janz R. SV2B regulates synaptotagmin 1 by direct interaction. J Biol Chem. 2004;279:52124-52131.
46. Wang MM, Janz R, Belizaire R, Frishman LJ, Sherry DM. Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina. J Comp Neurol. 2003;460:106-122.
47. von Kriegstein K, Schmitz F. The expression pattern and assembly profile of synaptic membrane proteins in ribbon synapses of the developing mouse retina. Cell Tissue Res. 2003;311:159-173.
48. Clegg N, Ferguson C, True LD, et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate. 2003;55:55-64.
49. Hayashi M, Yamamoto A, Yatsushiro S, et al. Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes. J Neurochem. 1998;71:356-365.
50. Rastaldi MP, Armelloni S, Berra S, et al. Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a. Am J Pathol. 2003;163:889-899.
51. Coward BJ, Welsh GI, Koziell A, et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes. 2007;56:1127-1135.
52. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell. 1997;90:403-404.
53. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signaling. Nat Rev Mol Cell Biol. 2002;3:475-486.
54. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005;6:462-475.
55. Martinez A, Soriano E. Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev. 2005;49:211-226.
56. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell. 2002;7:465-480.
57. Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 2002;13:75-85.
58. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
59. Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1992;90:766-771.
60. Remuzzi A, Perico N, Amuchastegui CS, et al. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol. 1993;4:40-49.
61. Nakamura T, Obata J, Kimura H, et al. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int. 1999;55:877-889.